Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.27637978 |
2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.27637978 |
3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.27637978 |
4 | modulation by symbiont of host immune response (GO:0052553) | 6.27637978 |
5 | positive regulation by symbiont of host defense response (GO:0052509) | 6.27637978 |
6 | modulation by symbiont of host defense response (GO:0052031) | 6.27637978 |
7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.21054617 |
8 | neutrophil activation involved in immune response (GO:0002283) | 4.74432727 |
9 | response to peptidoglycan (GO:0032494) | 4.74382716 |
10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.68653933 |
11 | positive regulation of interferon-alpha production (GO:0032727) | 4.37359410 |
12 | macrophage activation involved in immune response (GO:0002281) | 4.29569848 |
13 | regulation of interferon-alpha production (GO:0032647) | 4.17507960 |
14 | response to host immune response (GO:0052572) | 3.99424039 |
15 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.99424039 |
16 | microglial cell activation (GO:0001774) | 3.98361869 |
17 | immunoglobulin mediated immune response (GO:0016064) | 3.93672902 |
18 | response to muramyl dipeptide (GO:0032495) | 3.87576675 |
19 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.72725892 |
20 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.65955765 |
21 | positive regulation of antigen processing and presentation (GO:0002579) | 3.65735178 |
22 | response to host (GO:0075136) | 3.65682945 |
23 | response to host defenses (GO:0052200) | 3.65682945 |
24 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.65682945 |
25 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.63531820 |
26 | neutrophil activation (GO:0042119) | 3.57935340 |
27 | * response to lipoprotein particle (GO:0055094) | 3.56083381 |
28 | respiratory burst (GO:0045730) | 3.53520460 |
29 | granulocyte activation (GO:0036230) | 3.48201518 |
30 | positive regulation of interferon-beta production (GO:0032728) | 3.44088499 |
31 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.36412959 |
32 | natural killer cell mediated immunity (GO:0002228) | 3.36412959 |
33 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.35709293 |
34 | cellular response to ethanol (GO:0071361) | 3.28844909 |
35 | regulation of antigen processing and presentation (GO:0002577) | 3.22280250 |
36 | pinocytosis (GO:0006907) | 3.19728090 |
37 | myeloid cell activation involved in immune response (GO:0002275) | 3.16572006 |
38 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.15918431 |
39 | macrophage activation (GO:0042116) | 3.13708455 |
40 | * cell adhesion mediated by integrin (GO:0033627) | 3.10626999 |
41 | I-kappaB phosphorylation (GO:0007252) | 3.09700834 |
42 | osteoclast differentiation (GO:0030316) | 3.09349071 |
43 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.07151831 |
44 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.06954657 |
45 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.05962648 |
46 | negative regulation of interleukin-12 production (GO:0032695) | 3.04568001 |
47 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.03479591 |
48 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.99181831 |
49 | superoxide anion generation (GO:0042554) | 2.96176059 |
50 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.94515941 |
51 | B cell mediated immunity (GO:0019724) | 2.93967636 |
52 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.89575774 |
53 | NIK/NF-kappaB signaling (GO:0038061) | 2.89494845 |
54 | cytokine secretion (GO:0050663) | 2.88821804 |
55 | detection of molecule of bacterial origin (GO:0032490) | 2.88642719 |
56 | regulation of mononuclear cell migration (GO:0071675) | 2.88379118 |
57 | response to type I interferon (GO:0034340) | 2.86959145 |
58 | cellular response to type I interferon (GO:0071357) | 2.86279044 |
59 | type I interferon signaling pathway (GO:0060337) | 2.86279044 |
60 | regulation of mast cell degranulation (GO:0043304) | 2.81574382 |
61 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.81045112 |
62 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.80355368 |
63 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.79401441 |
64 | leukocyte aggregation (GO:0070486) | 2.79105606 |
65 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.78827083 |
66 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.77527412 |
67 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.75957675 |
68 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.75957675 |
69 | leukocyte mediated cytotoxicity (GO:0001909) | 2.72288641 |
70 | cellular extravasation (GO:0045123) | 2.72261849 |
71 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.70140596 |
72 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.69711480 |
73 | regulation of interferon-beta production (GO:0032648) | 2.69086649 |
74 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.67758603 |
75 | positive regulation of interleukin-12 production (GO:0032735) | 2.66822814 |
76 | protein localization to endosome (GO:0036010) | 2.66779942 |
77 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.65522067 |
78 | positive regulation of B cell differentiation (GO:0045579) | 2.63986868 |
79 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.63694682 |
80 | negative regulation of interleukin-17 production (GO:0032700) | 2.62767055 |
81 | cellular response to interferon-beta (GO:0035458) | 2.62468557 |
82 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.60861519 |
83 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.60749863 |
84 | regulation of chronic inflammatory response (GO:0002676) | 2.60501369 |
85 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.59715660 |
86 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.58546881 |
87 | cellular response to interferon-alpha (GO:0035457) | 2.57784175 |
88 | myeloid leukocyte activation (GO:0002274) | 2.57437199 |
89 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.57026741 |
90 | response to interferon-alpha (GO:0035455) | 2.56967005 |
91 | regulation of vitamin metabolic process (GO:0030656) | 2.56074718 |
92 | regulation of mast cell activation (GO:0033003) | 2.55996946 |
93 | negative regulation of lipid storage (GO:0010888) | 2.53817220 |
94 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.53667406 |
95 | positive regulation of heat generation (GO:0031652) | 2.53275926 |
96 | modulation by symbiont of host cellular process (GO:0044068) | 2.52933706 |
97 | * neutrophil mediated immunity (GO:0002446) | 2.49429103 |
98 | negative regulation of mast cell activation (GO:0033004) | 2.49328519 |
99 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.49172378 |
100 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.47146957 |
101 | lymphocyte mediated immunity (GO:0002449) | 2.46798270 |
102 | positive regulation of mast cell activation (GO:0033005) | 2.46509645 |
103 | positive regulation of leukocyte degranulation (GO:0043302) | 2.46192487 |
104 | leukocyte cell-cell adhesion (GO:0007159) | 2.45860106 |
105 | regulation of fever generation (GO:0031620) | 2.45715916 |
106 | myeloid dendritic cell activation (GO:0001773) | 2.45474425 |
107 | T cell migration (GO:0072678) | 2.45189146 |
108 | cellular response to exogenous dsRNA (GO:0071360) | 2.44814572 |
109 | regulation of interleukin-12 production (GO:0032655) | 2.44663148 |
110 | B cell homeostasis (GO:0001782) | 2.44454398 |
111 | regulation of cholesterol storage (GO:0010885) | 2.43318004 |
112 | regulation of vascular endothelial growth factor production (GO:0010574) | 2.43075455 |
113 | cellular response to virus (GO:0098586) | 2.42897561 |
114 | negative regulation of B cell proliferation (GO:0030889) | 2.42257769 |
115 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.41775813 |
116 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.41767747 |
117 | nuclear pore complex assembly (GO:0051292) | 2.41452561 |
118 | regulation of RIG-I signaling pathway (GO:0039535) | 2.41084638 |
119 | pore complex assembly (GO:0046931) | 2.40641606 |
120 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.40451262 |
121 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.39803025 |
122 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.38695393 |
123 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.38038624 |
124 | positive regulation of interleukin-6 production (GO:0032755) | 2.37773153 |
125 | necroptotic process (GO:0070266) | 2.36948027 |
126 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.33951215 |
127 | nuclear pore organization (GO:0006999) | 2.32320520 |
128 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.31124386 |
129 | iron ion import (GO:0097286) | 2.30817311 |
130 | mRNA transcription (GO:0009299) | 2.30578282 |
131 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.24859894 |
132 | positive regulation of interleukin-1 production (GO:0032732) | 2.23506166 |
133 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.23307714 |
134 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.22134020 |
135 | * regulation of lymphocyte chemotaxis (GO:1901623) | 2.22055618 |
136 | eosinophil chemotaxis (GO:0048245) | 2.21631032 |
137 | interferon-gamma secretion (GO:0072643) | 2.21047358 |
138 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.20970699 |
139 | positive regulation of macrophage differentiation (GO:0045651) | 2.20297022 |
140 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.17899191 |
141 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.17552005 |
142 | substrate-dependent cell migration (GO:0006929) | 2.15897870 |
143 | hemidesmosome assembly (GO:0031581) | 2.15240313 |
144 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.15054939 |
145 | hepatocyte apoptotic process (GO:0097284) | 2.15019485 |
146 | regulation of heat generation (GO:0031650) | 2.13744548 |
147 | cellular response to molecule of bacterial origin (GO:0071219) | 2.13497908 |
148 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.13099424 |
149 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.12681859 |
150 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.12455461 |
151 | mammary gland epithelial cell proliferation (GO:0033598) | 2.11159885 |
152 | sphingosine metabolic process (GO:0006670) | 2.10032534 |
153 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872) | 2.09775017 |
154 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.09568860 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.02426860 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.59810105 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.72571629 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.14313767 |
5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.03859480 |
6 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.75726624 |
7 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.57389652 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.49740164 |
9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.33734989 |
10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.29912531 |
11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.16063885 |
12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.13957049 |
13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.94618545 |
14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.87616975 |
15 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.78791408 |
16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.74347883 |
17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.73036764 |
18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.71932009 |
19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.63696204 |
20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.59840242 |
21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.57794564 |
22 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.24718484 |
23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.20723953 |
24 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.17747204 |
25 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.09227040 |
26 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.01637902 |
27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.93086958 |
28 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.92231588 |
29 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.90282964 |
30 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.86327176 |
31 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.84553392 |
32 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.81227280 |
33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.79912340 |
34 | MYB_26560356_Chip-Seq_TH2_Human | 1.77186856 |
35 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.74186111 |
36 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.70758445 |
37 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.67742946 |
38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.67593698 |
39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.66199413 |
40 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.65322667 |
41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.64713507 |
42 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.64539936 |
43 | TP53_16413492_ChIP-PET_HCT116_Human | 1.60554994 |
44 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.60046335 |
45 | MYB_26560356_Chip-Seq_TH1_Human | 1.58485881 |
46 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.58145051 |
47 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.53713401 |
48 | * MAF_26560356_Chip-Seq_TH1_Human | 1.48652275 |
49 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.47449645 |
50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46882013 |
51 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.45878879 |
52 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44796965 |
53 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.42674930 |
54 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.42674930 |
55 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.41337633 |
56 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.39576584 |
57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34262324 |
58 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.32507378 |
59 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32463602 |
60 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30222724 |
61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.28751310 |
62 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.28680726 |
63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28538829 |
64 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26168496 |
65 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21863269 |
66 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.21540270 |
67 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.21540270 |
68 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.20892780 |
69 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.20767954 |
70 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.19149536 |
71 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17686482 |
72 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16555292 |
73 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.15525086 |
74 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.14985216 |
75 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.14139492 |
76 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.13634473 |
77 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13609164 |
78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13366940 |
79 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.12887240 |
80 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12530421 |
81 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12157564 |
82 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.12126981 |
83 | GATA3_26560356_Chip-Seq_TH2_Human | 1.09655418 |
84 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.09413134 |
85 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08665770 |
86 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.08546963 |
87 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08518375 |
88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08117068 |
89 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.07768604 |
90 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07396481 |
91 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.05734205 |
92 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05423208 |
93 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.05111059 |
94 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04384160 |
95 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.04270976 |
96 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03975745 |
97 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.03922799 |
98 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.03076851 |
99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02671824 |
100 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01983905 |
101 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01149128 |
102 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00686063 |
103 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99371039 |
104 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.98821868 |
105 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.98755843 |
106 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98017074 |
107 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 0.97717964 |
108 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.96464835 |
109 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.96047991 |
110 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.95737105 |
111 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95686951 |
112 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95392953 |
113 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95296855 |
114 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.94012095 |
115 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.93996763 |
116 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.93915707 |
117 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.93698023 |
118 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.93091514 |
119 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91118526 |
120 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89269583 |
121 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.88130969 |
122 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.88029765 |
123 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.87804977 |
124 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.87573135 |
125 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.86301033 |
126 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.85929154 |
127 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.84751563 |
128 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.82905800 |
129 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.80903382 |
130 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79977573 |
131 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79657960 |
132 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.79353484 |
133 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78397182 |
134 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77850946 |
135 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77727350 |
136 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.77370178 |
137 | MYC_22102868_ChIP-Seq_BL_Human | 0.76859088 |
138 | MAF_26560356_Chip-Seq_TH2_Human | 0.76545270 |
139 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.75953185 |
140 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75700135 |
141 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.75699746 |
142 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.74105910 |
143 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.73694814 |
144 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.71440412 |
145 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71409203 |
146 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.71125841 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.78972412 |
2 | MP0003436_decreased_susceptibility_to | 2.98454747 |
3 | MP0002877_abnormal_melanocyte_morpholog | 2.85897108 |
4 | * MP0002419_abnormal_innate_immunity | 2.72680889 |
5 | MP0009785_altered_susceptibility_to | 2.71049396 |
6 | MP0005000_abnormal_immune_tolerance | 2.67459173 |
7 | MP0005058_abnormal_lysosome_morphology | 2.66944063 |
8 | MP0006082_CNS_inflammation | 2.66402800 |
9 | MP0002148_abnormal_hypersensitivity_rea | 2.63698652 |
10 | MP0003303_peritoneal_inflammation | 2.57467085 |
11 | MP0001790_abnormal_immune_system | 2.46121313 |
12 | MP0005387_immune_system_phenotype | 2.46121313 |
13 | * MP0002452_abnormal_antigen_presenting | 2.40439019 |
14 | MP0005025_abnormal_response_to | 2.35077471 |
15 | MP0001800_abnormal_humoral_immune | 2.34173195 |
16 | MP0000685_abnormal_immune_system | 2.33157638 |
17 | MP0002009_preneoplasia | 2.32126747 |
18 | MP0010234_abnormal_vibrissa_follicle | 2.26014720 |
19 | MP0003724_increased_susceptibility_to | 2.22302997 |
20 | MP0005671_abnormal_response_to | 2.18502507 |
21 | * MP0002723_abnormal_immune_serum | 2.17853607 |
22 | * MP0001819_abnormal_immune_cell | 2.00065240 |
23 | * MP0002420_abnormal_adaptive_immunity | 1.98180341 |
24 | MP0000569_abnormal_digit_pigmentation | 1.93609384 |
25 | MP0009278_abnormal_bone_marrow | 1.91268228 |
26 | * MP0010678_abnormal_skin_adnexa | 1.90030623 |
27 | MP0003448_altered_tumor_morphology | 1.89108516 |
28 | MP0003656_abnormal_erythrocyte_physiolo | 1.83308952 |
29 | MP0001533_abnormal_skeleton_physiology | 1.77111717 |
30 | * MP0004947_skin_inflammation | 1.75843279 |
31 | MP0008438_abnormal_cutaneous_collagen | 1.72997606 |
32 | MP0002405_respiratory_system_inflammati | 1.69998912 |
33 | MP0003300_gastrointestinal_ulcer | 1.68999172 |
34 | MP0001853_heart_inflammation | 1.68362857 |
35 | MP0003172_abnormal_lysosome_physiology | 1.65096783 |
36 | * MP0005464_abnormal_platelet_physiology | 1.63539457 |
37 | MP0001545_abnormal_hematopoietic_system | 1.55783176 |
38 | MP0005397_hematopoietic_system_phenotyp | 1.55783176 |
39 | * MP0000383_abnormal_hair_follicle | 1.54303367 |
40 | MP0002006_tumorigenesis | 1.50809056 |
41 | * MP0001845_abnormal_inflammatory_respons | 1.49843675 |
42 | MP0010307_abnormal_tumor_latency | 1.49740330 |
43 | * MP0000716_abnormal_immune_system | 1.48457249 |
44 | MP0002166_altered_tumor_susceptibility | 1.45716187 |
45 | MP0004510_myositis | 1.45542658 |
46 | * MP0002398_abnormal_bone_marrow | 1.44055848 |
47 | MP0009333_abnormal_splenocyte_physiolog | 1.41914196 |
48 | MP0003221_abnormal_cardiomyocyte_apopto | 1.37679932 |
49 | MP0002396_abnormal_hematopoietic_system | 1.36026781 |
50 | MP0000343_altered_response_to | 1.35675408 |
51 | MP0003566_abnormal_cell_adhesion | 1.35033539 |
52 | * MP0010155_abnormal_intestine_physiology | 1.32115380 |
53 | MP0005076_abnormal_cell_differentiation | 1.31161912 |
54 | MP0000858_altered_metastatic_potential | 1.31032112 |
55 | * MP0000689_abnormal_spleen_morphology | 1.30602350 |
56 | MP0009764_decreased_sensitivity_to | 1.28054316 |
57 | MP0004883_abnormal_blood_vessel | 1.26610589 |
58 | MP0009840_abnormal_foam_cell | 1.25623609 |
59 | * MP0008469_abnormal_protein_level | 1.25620911 |
60 | MP0003453_abnormal_keratinocyte_physiol | 1.24538709 |
61 | MP0003828_pulmonary_edema | 1.23785802 |
62 | MP0000465_gastrointestinal_hemorrhage | 1.22885573 |
63 | * MP0002429_abnormal_blood_cell | 1.21418005 |
64 | MP0003191_abnormal_cellular_cholesterol | 1.20163252 |
65 | MP0002933_joint_inflammation | 1.19480528 |
66 | MP0002277_abnormal_respiratory_mucosa | 1.19411967 |
67 | * MP0002998_abnormal_bone_remodeling | 1.19151982 |
68 | MP0005248_abnormal_Harderian_gland | 1.18949517 |
69 | MP0005257_abnormal_intraocular_pressure | 1.18855891 |
70 | MP0005451_abnormal_body_composition | 1.18677788 |
71 | MP0001958_emphysema | 1.17670889 |
72 | MP0004272_abnormal_basement_membrane | 1.17614007 |
73 | * MP0002722_abnormal_immune_system | 1.17369522 |
74 | MP0005310_abnormal_salivary_gland | 1.17356580 |
75 | MP0010352_gastrointestinal_tract_polyps | 1.17264554 |
76 | MP0002332_abnormal_exercise_endurance | 1.17219577 |
77 | MP0004808_abnormal_hematopoietic_stem | 1.15502076 |
78 | MP0008260_abnormal_autophagy | 1.14788665 |
79 | MP0002138_abnormal_hepatobiliary_system | 1.14714295 |
80 | MP0001851_eye_inflammation | 1.10737069 |
81 | MP0001216_abnormal_epidermal_layer | 1.10704841 |
82 | MP0003763_abnormal_thymus_physiology | 1.08633042 |
83 | MP0000537_abnormal_urethra_morphology | 1.07217262 |
84 | MP0005174_abnormal_tail_pigmentation | 1.07176887 |
85 | MP0005390_skeleton_phenotype | 1.06565548 |
86 | MP0005023_abnormal_wound_healing | 1.05577114 |
87 | MP0003091_abnormal_cell_migration | 1.00465348 |
88 | MP0004782_abnormal_surfactant_physiolog | 0.99442153 |
89 | MP0008057_abnormal_DNA_replication | 0.98613461 |
90 | MP0002254_reproductive_system_inflammat | 0.97422051 |
91 | MP0002896_abnormal_bone_mineralization | 0.96954108 |
92 | MP0008004_abnormal_stomach_pH | 0.96832433 |
93 | MP0009765_abnormal_xenobiotic_induced | 0.94314403 |
94 | MP0003690_abnormal_glial_cell | 0.94077060 |
95 | MP0000427_abnormal_hair_cycle | 0.93799652 |
96 | MP0000767_abnormal_smooth_muscle | 0.91321088 |
97 | MP0005171_absent_coat_pigmentation | 0.91048703 |
98 | MP0000490_abnormal_crypts_of | 0.89324796 |
99 | MP0001727_abnormal_embryo_implantation | 0.88621214 |
100 | MP0003705_abnormal_hypodermis_morpholog | 0.86214466 |
101 | MP0000371_diluted_coat_color | 0.85720590 |
102 | MP0003136_yellow_coat_color | 0.85423217 |
103 | MP0000015_abnormal_ear_pigmentation | 0.85385297 |
104 | MP0005167_abnormal_blood-brain_barrier | 0.85357930 |
105 | MP0005409_darkened_coat_color | 0.85096209 |
106 | MP0001915_intracranial_hemorrhage | 0.84932939 |
107 | MP0009053_abnormal_anal_canal | 0.84899490 |
108 | MP0003075_altered_response_to | 0.84141147 |
109 | MP0002060_abnormal_skin_morphology | 0.83688001 |
110 | MP0001873_stomach_inflammation | 0.82740752 |
111 | MP0004185_abnormal_adipocyte_glucose | 0.81943841 |
112 | MP0005164_abnormal_response_to | 0.80188197 |
113 | MP0004381_abnormal_hair_follicle | 0.79943894 |
114 | MP0000604_amyloidosis | 0.79463963 |
115 | MP0005647_abnormal_sex_gland | 0.77451814 |
116 | MP0001849_ear_inflammation | 0.76668981 |
117 | MP0000703_abnormal_thymus_morphology | 0.76334154 |
118 | MP0003279_aneurysm | 0.75917399 |
119 | * MP0009763_increased_sensitivity_to | 0.75700992 |
120 | MP0008007_abnormal_cellular_replicative | 0.75487059 |
121 | MP0003950_abnormal_plasma_membrane | 0.74671597 |
122 | MP0003632_abnormal_nervous_system | 0.74333325 |
123 | MP0006054_spinal_hemorrhage | 0.73777320 |
124 | MP0003183_abnormal_peptide_metabolism | 0.73195358 |
125 | MP0000249_abnormal_blood_vessel | 0.73063968 |
126 | MP0000733_abnormal_muscle_development | 0.72610369 |
127 | MP0005166_decreased_susceptibility_to | 0.72033636 |
128 | MP0003329_amyloid_beta_deposits | 0.70008961 |
129 | MP0000516_abnormal_urinary_system | 0.69935432 |
130 | MP0005367_renal/urinary_system_phenotyp | 0.69935432 |
131 | MP0000428_abnormal_craniofacial_morphol | 0.68054162 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 6.49165694 |
2 | Recurrent bacterial skin infections (HP:0005406) | 5.87752397 |
3 | Eczematoid dermatitis (HP:0000976) | 5.64204854 |
4 | Abnormality of macrophages (HP:0004311) | 4.59215350 |
5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.33307104 |
6 | Mediastinal lymphadenopathy (HP:0100721) | 3.94831519 |
7 | Vacuolated lymphocytes (HP:0001922) | 3.90735144 |
8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.89764535 |
9 | Increased cerebral lipofuscin (HP:0011813) | 3.80994493 |
10 | Autoimmune thrombocytopenia (HP:0001973) | 3.76021956 |
11 | Prostate neoplasm (HP:0100787) | 3.67673604 |
12 | Recurrent skin infections (HP:0001581) | 3.61964036 |
13 | Myositis (HP:0100614) | 3.61936352 |
14 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.59040680 |
15 | Chronic obstructive pulmonary disease (HP:0006510) | 3.58337692 |
16 | Obstructive lung disease (HP:0006536) | 3.58337692 |
17 | Subacute progressive viral hepatitis (HP:0006572) | 3.51148608 |
18 | Gingivitis (HP:0000230) | 3.50748314 |
19 | Stomatitis (HP:0010280) | 3.43632140 |
20 | Orchitis (HP:0100796) | 3.38544214 |
21 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.35232822 |
22 | Osteolytic defects of the hand bones (HP:0009699) | 3.35232822 |
23 | Recurrent fungal infections (HP:0002841) | 3.30569509 |
24 | Systemic lupus erythematosus (HP:0002725) | 3.26608513 |
25 | Optic neuritis (HP:0100653) | 3.25849425 |
26 | Retrobulbar optic neuritis (HP:0100654) | 3.25849425 |
27 | Abnormality of glycolipid metabolism (HP:0010969) | 2.99643089 |
28 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.99643089 |
29 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.99643089 |
30 | Recurrent viral infections (HP:0004429) | 2.99387179 |
31 | Periodontitis (HP:0000704) | 2.97125805 |
32 | Vasculitis (HP:0002633) | 2.91195409 |
33 | Cellulitis (HP:0100658) | 2.91165301 |
34 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.72436070 |
35 | Basal ganglia calcification (HP:0002135) | 2.65674914 |
36 | Osteomyelitis (HP:0002754) | 2.64068644 |
37 | Abnormality of the nasal septum (HP:0000419) | 2.62164692 |
38 | Disinhibition (HP:0000734) | 2.57275208 |
39 | Chronic otitis media (HP:0000389) | 2.54062842 |
40 | Recurrent pneumonia (HP:0006532) | 2.53934701 |
41 | Absent frontal sinuses (HP:0002688) | 2.52498129 |
42 | Myocardial infarction (HP:0001658) | 2.51096906 |
43 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.45661435 |
44 | Recurrent cutaneous fungal infections (HP:0011370) | 2.45661435 |
45 | Axonal loss (HP:0003447) | 2.43749724 |
46 | Fused cervical vertebrae (HP:0002949) | 2.42744655 |
47 | Glomerulonephritis (HP:0000099) | 2.42727241 |
48 | Curly hair (HP:0002212) | 2.41724228 |
49 | Stenosis of the external auditory canal (HP:0000402) | 2.41214256 |
50 | Meningitis (HP:0001287) | 2.41023892 |
51 | Abnormality of the frontal sinuses (HP:0002687) | 2.40796517 |
52 | * Thick nail (HP:0001805) | 2.36489646 |
53 | Papillary thyroid carcinoma (HP:0002895) | 2.36404426 |
54 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.33993472 |
55 | Interstitial pulmonary disease (HP:0006530) | 2.33489161 |
56 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.32329753 |
57 | Pulmonary infiltrates (HP:0002113) | 2.32183789 |
58 | Dysostosis multiplex (HP:0000943) | 2.31696932 |
59 | Thyroid carcinoma (HP:0002890) | 2.30247230 |
60 | Agnosia (HP:0010524) | 2.26849174 |
61 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.26492467 |
62 | * Leukocytosis (HP:0001974) | 2.26356711 |
63 | * Pustule (HP:0200039) | 2.25419046 |
64 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.25285597 |
65 | Short 1st metacarpal (HP:0010034) | 2.25285597 |
66 | Recurrent lower respiratory tract infections (HP:0002783) | 2.21431941 |
67 | Premature loss of primary teeth (HP:0006323) | 2.21097207 |
68 | Abnormality of the prostate (HP:0008775) | 2.20547197 |
69 | Hepatosplenomegaly (HP:0001433) | 2.19453074 |
70 | Urticaria (HP:0001025) | 2.18931665 |
71 | Spontaneous hematomas (HP:0007420) | 2.18337930 |
72 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.14744108 |
73 | Thyroiditis (HP:0100646) | 2.12751344 |
74 | Arterial thrombosis (HP:0004420) | 2.12495255 |
75 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.11050680 |
76 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.06946519 |
77 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.00957487 |
78 | Nephritis (HP:0000123) | 2.00418120 |
79 | Skin ulcer (HP:0200042) | 2.00252609 |
80 | Tetraparesis (HP:0002273) | 1.99833963 |
81 | Bladder neoplasm (HP:0009725) | 1.96914493 |
82 | Bladder carcinoma (HP:0002862) | 1.96914493 |
83 | Hemoptysis (HP:0002105) | 1.95066657 |
84 | Coarse hair (HP:0002208) | 1.94257393 |
85 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.94222884 |
86 | Keratoconjunctivitis sicca (HP:0001097) | 1.94219282 |
87 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.94132098 |
88 | Petechiae (HP:0000967) | 1.93932592 |
89 | Gingival bleeding (HP:0000225) | 1.92325725 |
90 | Keratitis (HP:0000491) | 1.91890534 |
91 | Neurofibrillary tangles (HP:0002185) | 1.91863004 |
92 | Emphysema (HP:0002097) | 1.91302988 |
93 | Cutaneous melanoma (HP:0012056) | 1.90418819 |
94 | Keratoconjunctivitis (HP:0001096) | 1.87674121 |
95 | Abnormality of oral frenula (HP:0000190) | 1.87341353 |
96 | Short humerus (HP:0005792) | 1.86462754 |
97 | Bone pain (HP:0002653) | 1.85601957 |
98 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.84906866 |
99 | Abnormality of the 1st metacarpal (HP:0010009) | 1.82836691 |
100 | Viral hepatitis (HP:0006562) | 1.82662986 |
101 | Alveolar cell carcinoma (HP:0006519) | 1.82207249 |
102 | Restrictive lung disease (HP:0002091) | 1.82159163 |
103 | Abnormality of T cell number (HP:0011839) | 1.81187604 |
104 | Vertebral compression fractures (HP:0002953) | 1.79624953 |
105 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.78746907 |
106 | Stomach cancer (HP:0012126) | 1.78604269 |
107 | Colitis (HP:0002583) | 1.78480708 |
108 | Loss of speech (HP:0002371) | 1.77008250 |
109 | Inflammation of the large intestine (HP:0002037) | 1.73973900 |
110 | Premature rupture of membranes (HP:0001788) | 1.73951752 |
111 | Abnormality of B cell number (HP:0010975) | 1.72974074 |
112 | Spastic diplegia (HP:0001264) | 1.72703617 |
113 | Autoimmune hemolytic anemia (HP:0001890) | 1.72480054 |
114 | Dislocated radial head (HP:0003083) | 1.72215516 |
115 | Cheilitis (HP:0100825) | 1.71828247 |
116 | Increased IgM level (HP:0003496) | 1.71827474 |
117 | Pathologic fracture (HP:0002756) | 1.70930591 |
118 | Tibial bowing (HP:0002982) | 1.69839642 |
119 | Cone-rod dystrophy (HP:0000548) | 1.69505497 |
120 | Submucous cleft hard palate (HP:0000176) | 1.69379806 |
121 | Alopecia of scalp (HP:0002293) | 1.68957417 |
122 | Abnormality of the pleura (HP:0002103) | 1.68870818 |
123 | T lymphocytopenia (HP:0005403) | 1.68328062 |
124 | Leukopenia (HP:0001882) | 1.67978210 |
125 | Persistence of primary teeth (HP:0006335) | 1.67792496 |
126 | Spondylolisthesis (HP:0003302) | 1.67726138 |
127 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.67642497 |
128 | Mucopolysacchariduria (HP:0008155) | 1.67642497 |
129 | Milia (HP:0001056) | 1.67362943 |
130 | Vitreoretinal degeneration (HP:0000655) | 1.67235853 |
131 | Poor head control (HP:0002421) | 1.66530424 |
132 | Albinism (HP:0001022) | 1.66518090 |
133 | Sepsis (HP:0100806) | 1.66341422 |
134 | Hypergammaglobulinemia (HP:0010702) | 1.65800321 |
135 | Amaurosis fugax (HP:0100576) | 1.65073705 |
136 | * Hematochezia (HP:0002573) | 1.64721057 |
137 | B lymphocytopenia (HP:0010976) | 1.64462336 |
138 | Syringomyelia (HP:0003396) | 1.64266308 |
139 | Spinal cord lesions (HP:0100561) | 1.64266308 |
140 | Adactyly (HP:0009776) | 1.64204358 |
141 | Chromsome breakage (HP:0040012) | 1.63469051 |
142 | Anhidrosis (HP:0000970) | 1.63428639 |
143 | Agammaglobulinemia (HP:0004432) | 1.63320060 |
144 | Peritonitis (HP:0002586) | 1.62990561 |
145 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.62936662 |
146 | Somatic mutation (HP:0001428) | 1.61863602 |
147 | Chest pain (HP:0100749) | 1.61546916 |
148 | Arterial tortuosity (HP:0005116) | 1.61185240 |
149 | Ectopic kidney (HP:0000086) | 1.60696254 |
150 | Ankyloglossia (HP:0010296) | 1.60095273 |
151 | Ectropion (HP:0000656) | 1.59315576 |
152 | Abnormality of the radial head (HP:0003995) | 1.58635909 |
153 | Increased CSF protein (HP:0002922) | 1.58433008 |
154 | Cubitus valgus (HP:0002967) | 1.57189654 |
155 | Hypoalphalipoproteinemia (HP:0003233) | 1.56604093 |
156 | Deep philtrum (HP:0002002) | 1.54242574 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRAK3 | 4.04690978 |
2 | IRAK4 | 3.57918514 |
3 | MAP3K14 | 3.53479227 |
4 | BLK | 3.20403344 |
5 | TYK2 | 2.84533942 |
6 | EIF2AK3 | 2.76639820 |
7 | TBK1 | 2.61173124 |
8 | MAP4K1 | 2.43159428 |
9 | BRD4 | 2.27014255 |
10 | TGFBR2 | 2.23123398 |
11 | ERBB3 | 2.21035518 |
12 | STK10 | 2.20735362 |
13 | KIT | 2.17822596 |
14 | JAK3 | 2.17712075 |
15 | IKBKB | 2.14155117 |
16 | RIPK4 | 2.13041580 |
17 | IKBKE | 2.03008067 |
18 | PBK | 1.93090848 |
19 | NEK9 | 1.92622993 |
20 | FER | 1.83564827 |
21 | ERBB4 | 1.82868408 |
22 | JAK1 | 1.70939124 |
23 | FRK | 1.70063897 |
24 | TXK | 1.69228811 |
25 | BCR | 1.57926945 |
26 | CSF1R | 1.52842049 |
27 | STK38L | 1.51504276 |
28 | KSR1 | 1.47935147 |
29 | RPS6KA4 | 1.46654977 |
30 | MARK3 | 1.42121677 |
31 | FLT3 | 1.40641230 |
32 | CHUK | 1.40584976 |
33 | SIK3 | 1.39135200 |
34 | STK3 | 1.36110321 |
35 | CSK | 1.34445898 |
36 | NTRK1 | 1.32740091 |
37 | ZAK | 1.32411936 |
38 | EPHB1 | 1.31628995 |
39 | CLK1 | 1.28784624 |
40 | ZAP70 | 1.24599902 |
41 | HCK | 1.20799982 |
42 | PIM1 | 1.18882208 |
43 | STK4 | 1.18389014 |
44 | PIM2 | 1.17266739 |
45 | TEC | 1.16712243 |
46 | PLK4 | 1.15839142 |
47 | TRPM7 | 1.15256726 |
48 | TAOK3 | 1.14657842 |
49 | MAP3K13 | 1.14489942 |
50 | TTN | 1.08387564 |
51 | BTK | 1.07815834 |
52 | ERN1 | 1.05946944 |
53 | EIF2AK2 | 1.05542178 |
54 | LYN | 1.04955612 |
55 | CDK12 | 1.04227990 |
56 | ITK | 0.95303382 |
57 | SYK | 0.95236796 |
58 | * LCK | 0.94145306 |
59 | NUAK1 | 0.93850355 |
60 | IRAK1 | 0.91440609 |
61 | BMPR1B | 0.90432037 |
62 | FGR | 0.85974919 |
63 | LRRK2 | 0.85418117 |
64 | CAMK1D | 0.85075363 |
65 | TIE1 | 0.84771516 |
66 | CSNK1A1L | 0.83765616 |
67 | STK39 | 0.83399818 |
68 | FGFR3 | 0.83252782 |
69 | NME2 | 0.82648644 |
70 | MAP2K3 | 0.81375096 |
71 | PDGFRA | 0.81208233 |
72 | MAP3K3 | 0.80888095 |
73 | MST4 | 0.79654513 |
74 | TRIM28 | 0.79653905 |
75 | IRAK2 | 0.77527872 |
76 | TGFBR1 | 0.77119948 |
77 | MET | 0.76573052 |
78 | MAP4K2 | 0.76560366 |
79 | SGK3 | 0.74668288 |
80 | MKNK1 | 0.74468090 |
81 | JAK2 | 0.74439744 |
82 | MELK | 0.72709235 |
83 | GRK7 | 0.71941374 |
84 | ABL1 | 0.71936995 |
85 | CDK6 | 0.71747132 |
86 | KDR | 0.69984002 |
87 | ERBB2 | 0.69970407 |
88 | PKN2 | 0.69856499 |
89 | FGFR4 | 0.66610030 |
90 | ACVR1B | 0.66434456 |
91 | AKT3 | 0.66343712 |
92 | TNIK | 0.66218918 |
93 | MATK | 0.63245645 |
94 | CAMKK2 | 0.62579358 |
95 | ADRBK2 | 0.62092360 |
96 | MKNK2 | 0.58469951 |
97 | LATS1 | 0.57683604 |
98 | PTK2B | 0.57483288 |
99 | BMX | 0.57435787 |
100 | INSR | 0.57097775 |
101 | MAP3K8 | 0.55900082 |
102 | YES1 | 0.54812232 |
103 | PDGFRB | 0.53907879 |
104 | MAP3K2 | 0.53693607 |
105 | MOS | 0.52795351 |
106 | NEK6 | 0.52739657 |
107 | EGFR | 0.52348322 |
108 | PAK4 | 0.52042089 |
109 | NEK2 | 0.51790488 |
110 | MAPKAPK2 | 0.51484714 |
111 | EPHA3 | 0.50514502 |
112 | CSNK1G2 | 0.50462076 |
113 | BRSK2 | 0.50250799 |
114 | LATS2 | 0.49075722 |
115 | RPS6KA5 | 0.48757325 |
116 | DDR2 | 0.48606182 |
117 | PTK6 | 0.48122835 |
118 | MAP3K10 | 0.47356079 |
119 | TTK | 0.47126704 |
120 | RIPK1 | 0.46906143 |
121 | CDK4 | 0.46444716 |
122 | CSNK1G1 | 0.45413102 |
123 | FES | 0.43270143 |
124 | SGK2 | 0.43015435 |
125 | MAP3K1 | 0.42419220 |
126 | STK24 | 0.41758105 |
127 | NLK | 0.41000876 |
128 | PRKCQ | 0.39595303 |
129 | EPHA2 | 0.39105387 |
130 | BMPR2 | 0.38503798 |
131 | ABL2 | 0.36899761 |
132 | * PRKCD | 0.35627081 |
133 | MST1R | 0.35421280 |
134 | ATR | 0.33398699 |
135 | CDK9 | 0.29804813 |
136 | IGF1R | 0.29427727 |
137 | MAP3K5 | 0.29302234 |
138 | BUB1 | 0.27890806 |
139 | CAMK1G | 0.27309069 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.85999222 |
2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.67395113 |
3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.64005906 |
4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.39003958 |
5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.23012335 |
6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.16004001 |
7 | Malaria_Homo sapiens_hsa05144 | 2.13455765 |
8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.11901096 |
9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.06021932 |
10 | Measles_Homo sapiens_hsa05162 | 2.02195009 |
11 | Legionellosis_Homo sapiens_hsa05134 | 1.98107782 |
12 | Pertussis_Homo sapiens_hsa05133 | 1.94944017 |
13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.93001272 |
14 | Lysosome_Homo sapiens_hsa04142 | 1.90469527 |
15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.79070272 |
16 | Tuberculosis_Homo sapiens_hsa05152 | 1.78424598 |
17 | Allograft rejection_Homo sapiens_hsa05330 | 1.76862258 |
18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.75734695 |
19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.75134935 |
20 | Influenza A_Homo sapiens_hsa05164 | 1.68256631 |
21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.67050846 |
22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.65753525 |
23 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.64124698 |
24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63492017 |
25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.62467695 |
26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.62241924 |
27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.61407343 |
28 | Asthma_Homo sapiens_hsa05310 | 1.51458739 |
29 | Apoptosis_Homo sapiens_hsa04210 | 1.49840668 |
30 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.47460171 |
31 | Phagosome_Homo sapiens_hsa04145 | 1.40698346 |
32 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.37284590 |
33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.34450594 |
34 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.33200194 |
35 | Salmonella infection_Homo sapiens_hsa05132 | 1.29654162 |
36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.29653551 |
37 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26174853 |
38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.25293327 |
39 | Shigellosis_Homo sapiens_hsa05131 | 1.25168703 |
40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24435666 |
41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.23607136 |
42 | Viral myocarditis_Homo sapiens_hsa05416 | 1.23045533 |
43 | Hepatitis B_Homo sapiens_hsa05161 | 1.20940668 |
44 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.20402051 |
45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.19470666 |
46 | Thyroid cancer_Homo sapiens_hsa05216 | 1.12337365 |
47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09976626 |
48 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.08920385 |
49 | Hepatitis C_Homo sapiens_hsa05160 | 1.06481389 |
50 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02932437 |
51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.00380264 |
52 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99782591 |
53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98140250 |
54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.95982550 |
55 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94054788 |
56 | Bladder cancer_Homo sapiens_hsa05219 | 0.93695829 |
57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.93579931 |
58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.92007473 |
59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.91205505 |
60 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.90024202 |
61 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88092673 |
62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.87343242 |
63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86355298 |
64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85896133 |
65 | Amoebiasis_Homo sapiens_hsa05146 | 0.84611675 |
66 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.83651585 |
67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.83206479 |
68 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81979738 |
69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.81435141 |
70 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.79592249 |
71 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.70826769 |
72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70022466 |
73 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.69539957 |
74 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68313974 |
75 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.65608033 |
76 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65287529 |
77 | Platelet activation_Homo sapiens_hsa04611 | 0.64384616 |
78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61151198 |
79 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.60529338 |
80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60378962 |
81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59179671 |
82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57729836 |
83 | Prostate cancer_Homo sapiens_hsa05215 | 0.56258465 |
84 | Adherens junction_Homo sapiens_hsa04520 | 0.55806702 |
85 | Melanoma_Homo sapiens_hsa05218 | 0.55507851 |
86 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55316654 |
87 | Cell cycle_Homo sapiens_hsa04110 | 0.54975531 |
88 | Focal adhesion_Homo sapiens_hsa04510 | 0.53582906 |
89 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53375669 |
90 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.53078805 |
91 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.51635304 |
92 | DNA replication_Homo sapiens_hsa03030 | 0.50451447 |
93 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50144320 |
94 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49322757 |
95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49127198 |
96 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.48935372 |
97 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.48219296 |
98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48175092 |
99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47847931 |
100 | Glioma_Homo sapiens_hsa05214 | 0.47228223 |
101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.45897972 |
102 | * Notch signaling pathway_Homo sapiens_hsa04330 | 0.44365474 |
103 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.41796327 |
104 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41701181 |
105 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.41574318 |
106 | Homologous recombination_Homo sapiens_hsa03440 | 0.41067160 |
107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40892827 |
108 | Pathways in cancer_Homo sapiens_hsa05200 | 0.38774905 |
109 | Endocytosis_Homo sapiens_hsa04144 | 0.37916672 |
110 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35521496 |
111 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.35233311 |
112 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.35064825 |
113 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34268729 |
114 | Base excision repair_Homo sapiens_hsa03410 | 0.34117952 |
115 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.33987056 |
116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.33458452 |
117 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.32302599 |
118 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.32076744 |
119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32029472 |